PCSK9 and cancer: This combined entity was then bonded to liposomal nanoparticles to enhance the vaccine’s capability to invoke specific immunity significantly.442 The anti-PCSK9 vaccine effectively triggered the production of PCSK9-specific antibodies and inhibited PCSK9 levels and functionality in various mouse cancer models.